Researcher Database

Inagaki Takahito

FacultyHospital Pharmaceutics
PositionAssistant Professor
Last Updated :2026/08/04

Researcher

基本情報

Profile and Settings

  • 氏名

    Inagaki Takahito

Affiliation

  • Hospital Pharmaceutics, Assistant Professor

Location

  • Hatanodai Campus

Achievements

Published Papers

  • Takahito Inagaki, Miki Sato, Masaoki Kin, Koji Otsuka, Masahiko Murakami, Mari Kogo, Takahito Inagaki, Miki Sato, Masaoki Kin, Koji Otsuka, Masahiko Murakami, Mari Kogo, Oncology, Aug. 2026, Peer-reviewed
  • Linezolid as a potential alternative to glycopeptide in treating Enterococcus faecium suspected cyst infection in a hemodialysis patient with autosomal-dominant polycystic kidney disease: A case report, Takahito Inagaki; Mai Otsu; Akitoshi Takuma; Kenji Momo, Sage Open Medical Case Reports, 14:1 - 6, Jul. 2026, Peer-reviewed
  • Black Pigmentation on the Tongue Induced by Long-Term Use of Tetracycline Antibiotics in a Colorectal Cancer Patient With Epidermal Growth Factor Receptor (EGFR) Inhibitor-Associated Skin Lesions: A Case Report and Literature Review., Inagaki Takahito;Ichimura Takenori;Ichikura Daisuke;Wakamura Kunihiko;Nawata Shuichi, Cureus, 17(2), Feb. 2025, Peer-reviewed
  • Relationship between the combination of platelet count and neutrophil-lymphocyte ratio and prognosis of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective cohort study., Kashimura Saeko;Sato Miki;Inagaki Takahito;Kin Masaoki;Manabe Ryo;Kusumoto Sojiro;Horiike Atsushi;Tsunoda Takuya;Kogo Mari, Thoracic cancer, 15(28), Aug. 2024, Peer-reviewed
  • Predictive Factors of Febrile Neutropenia After Primary Prophylactic Pegfilgrastim With DCF Chemotherapy for Esophageal Cancer., Inagaki Takahito;Sato Miki;Kin Masaoki;Otsuka Koji;Murakami Masahiko;Kogo Mari, Anticancer research, 42(12), 2022, Peer-reviewed


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.